Gubra A/S is a biotechnology company focused on the development and discovery of peptide-based therapies targeting metabolic, fibrotic, and gastrointestinal diseases. As a key player in the biotech se... Gubra A/S is a biotechnology company focused on the development and discovery of peptide-based therapies targeting metabolic, fibrotic, and gastrointestinal diseases. As a key player in the biotech sector, Gubra A/S works at the forefront of scientific research to address complex health challenges by leveraging advanced peptide chemistry and integrated research methodologies. The company's innovative approach significantly impacts the pharmaceutical industry as it enhances the drug development process through collaboration with global pharmaceutical firms. Gubra's commitment to providing cutting-edge solutions not only advances therapeutic options but also contributes to our understanding of metabolic and fibrotic pathways. Headquartered in Denmark, Gubra A/S plays a pivotal role in expanding the capabilities of biotech research, emphasizing the importance of peptide-based treatments in improving patient outcomes across various diseases.
Pending data availability
EU Taxonomy Data missing for Gubra
We haven’t collected EU Taxonomy data for Gubra yet, or the company
hasn’t made it publicly available.